TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
TIL

Instil Bio Inc.

Healthcare · Biotechnology

7.20$ +1.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Instil Bio Inc. (TIL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 198 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TIL
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 319 696 673 647 610 565 569 533 482 427 408 340 326 306 294 273 264 237 231 212 204 200 198
– – – 246 614 574 523 464 391 368 314 269 240 221 196 161 161 155 133 124 219 207 196 191 188 72
– – – 242 610 567 20 38 61 42 41 44 27 22 9.1 9.2 5.5 6.8 6.7 8.8 15 7.7 5.8 6.6 5.0 5.5
– – – 242 610 567 515 454 380 355 303 261 223 202 183 150 154 149 120 113 104 92 80 76 75 70
– – – 3.2 1.3 1.3 1.3 8.1 3.1 4.3 5.0 – – – – – – – 2.9 2.6 0.9 0.8 0.8 0.8 0.0 0.0
– – – 1.2 2.0 – – – – – – – – – – – – – – – – – – – – –
– – – – 63 79 104 122 141 167 198 – 180 181 – – – – – – – – – – – –
– – – 5.7 5.7 5.7 5.7 5.7 5.7 5.7 5.7 0.0 – – – – – – – – – – – – – –
– – – 10 10 10 10 10 10 10 10 – – – – – – – – – – – – – – –
– – – 27 31 37 46 55 56 110 122 119 116 112 106 100 100 99 96 94 93 99 91 90 90 90
– – – 13 17 24 32 41 37 43 42 33 27 18 13 11 11 10 10 7.9 7.2 14 5.7 4.8 4.7 3.3
– – – – – – – – 1.9 2.0 2.3 2.4 2.1 1.9 1.8 1.8 1.7 1.7 1.8 1.7 2.4 0.5 0.3 0.4 0.2 –
– – – 3.5 3.7 5.2 5.3 5.6 7.7 5.8 5.3 2.4 1.3 2.2 1.6 1.2 1.2 1.2 1.2 0.7 0.3 0.5 0.9 0.8 0.8 0.8
– – – – – – – – – 49 63 72 77 82 81 81 82 82 82 84 84 84 85 85 85 85
– – – 292 665 635 601 555 509 458 411 364 311 297 234 226 206 195 176 169 145 132 120 114 111 107
– – – -45 -68 -103 -146 -202 -256 -315 -371 -425 -482 -501 -568 -581 -605 -620 -643 -655 -683 -705 -718 -726 -731 -735
6.4 6.4 6.4 6.4 6.4 6.4 6.4 6.4 6.5 6.5 6.5 6.5 6.5 6.5 6.5 6.5 6.5 6.5 6.5 6.5 6.5 6.6 6.8 6.8 6.8 6.8

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?